Cargando…

Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection

BACKGROUND: National immunisation programmes globally are at risk of suspension due to the severe health system constraints and physical distancing measures in place to mitigate the ongoing COVID-19 pandemic. We aimed to compare the health benefits of sustaining routine childhood immunisation in Afr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbas, Kaja, Procter, Simon R, van Zandvoort, Kevin, Clark, Andrew, Funk, Sebastian, Mengistu, Tewodaj, Hogan, Dan, Dansereau, Emily, Jit, Mark, Flasche, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367673/ https://www.ncbi.nlm.nih.gov/pubmed/32687792 http://dx.doi.org/10.1016/S2214-109X(20)30308-9

Ejemplares similares

SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study
por: Procter, Simon R., et al.
Publicado: (2021)

SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study
por: Procter, Simon R, et al.
Publicado: (2021)

Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries
por: Cata-Preta, Bianca O., et al.
Publicado: (2021)

Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study
por: Auzenbergs, Megan, et al.
Publicado: (2023)

Disruptions to childhood immunisation due to the COVID-19 pandemic
por: Abbas, Kaja, et al.
Publicado: (2021)

Assessing the overlap between immunisation and other essential health interventions in 92 low- and middle-income countries using household surveys: opportunities for expanding immunisation and primary health care
por: Santos, Thiago M, et al.
Publicado: (2021)

Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis
por: Liu, Yang, et al.
Publicado: (2022)

Ethnic disparities in immunisation: analyses of zero-dose prevalence in 64 countries
por: Cata-Preta, Bianca O, et al.
Publicado: (2022)

Serostatus testing and dengue vaccine cost–benefit thresholds
por: Pearson, Carl A. B., et al.
Publicado: (2019)

COVID-19's lost generation of unvaccinated children – Authors' reply
por: Abbas, Kaja, et al.
Publicado: (2021)

Descriptive analysis of routine childhood immunisation timeliness in the Western Cape, South Africa
por: Blose, Ntombifuthi, et al.
Publicado: (2021)

COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery
por: Toor, Jaspreet, et al.
Publicado: (2022)

Equity assessment of childhood immunisation at national and subnational levels in Myanmar: a benefit incidence analysis
por: Win, Zin Mar, et al.
Publicado: (2022)

Childhood immunisation timeliness and vaccine confidence by health information source, maternal, socioeconomic, and geographic characteristics in Albania
por: Mayerová, Daniela, et al.
Publicado: (2021)

Routine immunisations: reversing the decline
por: The Lancet
Publicado: (2023)

Inequities in childhood immunisation coverage associated with socioeconomic, geographic, maternal, child, and place of birth characteristics in Kenya
por: Allan, Simon, et al.
Publicado: (2021)

Evaluation of the Benefits and Risks of Introducing Ebola Community Care Centers, Sierra Leone
por: Kucharski, Adam J., et al.
Publicado: (2015)

Non-specific immunological effects of selected routine childhood immunisations: systematic review
por: Kandasamy, Rama, et al.
Publicado: (2016)

Routine immunisation programmes in southeast Asia: beyond the routine
por: The Lancet Regional Health – Southeast Asia
Publicado: (2023)

The future of childhood immunisation
por: Burki, Talha
Publicado: (2023)

Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules
por: Clark, Andrew, et al.
Publicado: (2019)

Correspondence to: Estimating the full health and economic benefits of current and future influenza vaccines
por: Waterlow, Naomi R., et al.
Publicado: (2023)

Registries: An essential tool for maximising the health benefits of immunisation in the 21st century
por: Crowcroft, N S, et al.
Publicado: (2017)

Using record linkage to demonstrate the benefits of maternal influenza immunisation in Western Australia
por: Regan, Annette, et al.
Publicado: (2017)

A review of the costs of delivering maternal immunisation during pregnancy
por: Procter, Simon R, et al.
Publicado: (2020)

Inequalities in COVID-19 disruption of routine immunisations and returning to pre-COVID immunisation rates
por: Chandir, Subhash, et al.
Publicado: (2021)

The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya
por: Mburu, C. N., et al.
Publicado: (2021)

Household cost-benefit equations and sustainable universal childhood immunisation: a randomised cluster controlled trial in south Pakistan [ISRCTN12421731]
por: Andersson, Neil, et al.
Publicado: (2005)

Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study
por: Abbas, Kaja M, et al.
Publicado: (2020)

Strengthening national vaccine decision-making: Assessing the impact of SIVAC Initiative support on national immunisation technical advisory group (NITAG) functionality in 77 low and middle-income countries
por: van Zandvoort, Kevin, et al.
Publicado: (2019)

Improving routine childhood immunisation outcomes in low-income and middle-income countries: an evidence gap map
por: Engelbert, Mark, et al.
Publicado: (2022)

Vaccine-derived polio in Peru after 32 years of elimination: reflections on the routine childhood immunisation coverages
por: Al-kassab-Córdova, Ali, et al.
Publicado: (2023)

Impact of COVID-19 on routine childhood immunisations in low- and middle-income countries: A scoping review
por: Dalton, Milena, et al.
Publicado: (2023)

Benefits of risk‐adapted and mould‐specific antifungal prophylaxis in childhood leukaemia
por: Meryk, Andreas, et al.
Publicado: (2020)

Risk Benefit Analysis of Routine Thymectomy for Differentiated Thyroid Cancers: A Systematic Review
por: Kaul, Pallvi, et al.
Publicado: (2021)

Inequalities in Childhood Immunisation in South Asia
por: Atteraya, Madhu Sudhan, et al.
Publicado: (2023)

Adding new childhood vaccines to China's National Immunization Program: evidence, benefits, and priorities
por: Zhang, Haijun, et al.
Publicado: (2023)

Risk–benefit and cost–benefit ratio in headache treatment
por: Pini, L. A., et al.
Publicado: (2005)

Using routinely collected data to improve immunisation histories
por: Allen, Luke
Publicado: (2013)

The SARS-CoV2 pandemic and routine immunisation
por: Kang, Gagandeep
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5976nnj0qjkau6ff94m0fgh96u